Report: Hemp industry lawsuit challenging DEA’s position on CBD picks up support of 28 U.S. legislators

The Cannabist writes, “A bipartisan congressional coalition pushed back on the U.S. Drug Enforcement Administration’s assertion that cannabidiol and extracts derived from hemp are Schedule I substances.”


Go to Source

Powered by WPeMatico